
Enoxaparin Sodium APIs and Preparations - Global and China Top Players Market Share and Ranking 2023
The Global Enoxaparin Sodium APIs and Preparations Market investigation report contains Types, Application & all logical and factual briefs about market 2024 Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like Sanofi, Pfizer, Amphastar, Techdow, Sandoz, Fresenius Kabi, Dr. Reddys, Hikma, Aspen Pharma, LEO Pharma, Teva, Aurobindo, Lupin, Mylan, Bioibérica, Cipla, Jiangsu Hengrui, Nanjing King-Friend, Changzhou Qianhong, Bharat Serums
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for Enoxaparin Sodium APIs and Preparations should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Enoxaparin Sodium APIs and Preparations market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Enoxaparin Sodium APIs and Preparations market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Deep Vein Thrombosis grew percent to account for percent of the total market sales, and Pulmonary Embolism grew percent.
This report studies and analyses global Enoxaparin Sodium APIs and Preparations status and future trends, helps the client to determine the Enoxaparin Sodium APIs and Preparations market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Enoxaparin Sodium APIs and Preparations, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Enoxaparin Sodium APIs and Preparations market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Enoxaparin Sodium APIs and Preparations sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Enoxaparin Sodium APIs and Preparations sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Enoxaparin Sodium APIs and Preparations key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Enoxaparin Sodium APIs and Preparations key producing regions, capacity, production, and year over year growth
(6) Enoxaparin Sodium APIs and Preparations industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Shandong Haike Chemical Group Co., Ltd
Manus Aktteva Biopharma LLP
Chemi SPA
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Venus Remedies Ltd
JoinHub Pharma
Memphis Vision Care
Shenzhen Techdow Pharmaceutical Co., Ltd.
Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
Meithal Pharmaceuticals
Gland Pharma
Dongying Tiandong Pharmaceutical Co., Ltd.
Market segment by Type, covers
20 mg/0.2mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL
Market segment by Application, can be divided into
Deep Vein Thrombosis
Pulmonary Embolism
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Enoxaparin Sodium APIs and Preparations product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Enoxaparin Sodium APIs and Preparations market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Enoxaparin Sodium APIs and Preparations market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Enoxaparin Sodium APIs and Preparations, percent & CAGR, 2018-2029
Chapter 5: Enoxaparin Sodium APIs and Preparations industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Enoxaparin Sodium APIs and Preparations Definition
1.2 Global Enoxaparin Sodium APIs and Preparations Market Size and Forecast
1.2.1 By Consumption Value, Global Enoxaparin Sodium APIs and Preparations Market Size,2019-2030
1.2.2 By Sales Quantity, Global Enoxaparin Sodium APIs and Preparations Market Size,2019-2030
1.2.3 Global Enoxaparin Sodium APIs and Preparations Average Selling Price (ASP),2019-2030
1.3 China Enoxaparin Sodium APIs and Preparations Market Size and Forecast
1.3.1 By Consumption Value, China Enoxaparin Sodium APIs and Preparations Market Size,2019-2030
1.3.2 By Sales Quantity, China Enoxaparin Sodium APIs and Preparations Market Size,2019-2030
1.3.3 China Enoxaparin Sodium APIs and Preparations Average Selling Price (ASP), 2019-2030
1.4 Share of China Enoxaparin Sodium APIs and Preparations Market with Respect to the Global Market
1.4.1 By Consumption Value, China Enoxaparin Sodium APIs and Preparations Market Share in Global, 2019-2030
1.4.2 By Sales Quantity, China Enoxaparin Sodium APIs and Preparations Market Share in Global, 2019-2030
1.4.3 Enoxaparin Sodium APIs and Preparations Market Size: China VS Global, 2019-2030
1.5 Enoxaparin Sodium APIs and Preparations Market Dynamics
1.5.1 Enoxaparin Sodium APIs and Preparations Market Drivers
1.5.2 Enoxaparin Sodium APIs and Preparations Market Restraints
1.5.3 Enoxaparin Sodium APIs and Preparations Industry Trends
1.5.4 Enoxaparin Sodium APIs and Preparations Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Enoxaparin Sodium APIs and Preparations, Global Market Share by Company, 2019-2024
2.2 By Sales Quantity of Enoxaparin Sodium APIs and Preparations, Global Market Share by Company, 2019-2024
2.3 Enoxaparin Sodium APIs and Preparations Average Selling Price (ASP) by Company, 2019-2024
2.4 Global Enoxaparin Sodium APIs and Preparations Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Enoxaparin Sodium APIs and Preparations Concentration Ratio
2.6 Global Enoxaparin Sodium APIs and Preparations Mergers & Acquisitions, Expansion Plans
2.7 Global Enoxaparin Sodium APIs and Preparations Manufacturers Product Type
2.8 Head Office and Enoxaparin Sodium APIs and Preparations Production Site of Key Manufacturer
2.9 Enoxaparin Sodium APIs and Preparations Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Enoxaparin Sodium APIs and Preparations, China Market Share by Company, 2019-2024
3.2 By Sales Quantity of Enoxaparin Sodium APIs and Preparations, China Market Share by Company, 2019-2024
3.3 China Enoxaparin Sodium APIs and Preparations Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Enoxaparin Sodium APIs and Preparations Capacity, Output and Capacity Utilization, 2019-2030
4.2 Global Enoxaparin Sodium APIs and Preparations Capacity by Region
4.3 Global Enoxaparin Sodium APIs and Preparations Production & Forecast by Region, 2019 VS 2024 VS 2030
4.4 Global Enoxaparin Sodium APIs and Preparations Production by Region, 2019-2030
4.5 Global Enoxaparin Sodium APIs and Preparations Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Enoxaparin Sodium APIs and Preparations Industry Chain
5.2 Enoxaparin Sodium APIs and Preparations Upstream Analysis
5.2.1 Enoxaparin Sodium APIs and Preparations Core Raw Materials
5.2.2 Main Manufacturers of Enoxaparin Sodium APIs and Preparations Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Enoxaparin Sodium APIs and Preparations Production Mode
5.6 Enoxaparin Sodium APIs and Preparations Procurement Model
5.7 Enoxaparin Sodium APIs and Preparations Industry Sales Model and Sales Channels
5.7.1 Enoxaparin Sodium APIs and Preparations Sales Model
5.7.2 Enoxaparin Sodium APIs and Preparations Typical Distributors
6 Sights by Type
6.1 Enoxaparin Sodium APIs and Preparations Classification
6.1.1 20 mg/0.2mL
6.1.2 40 mg/0.4mL
6.1.3 60 mg/0.6mL
6.1.4 80 mg/0.8mL
6.1.5 100 mg/1mL
6.1.6 120 mg/0.8mL
6.1.7 150 mg/1mL
6.1.8 300mg/3mL
6.2 By Type, Global Enoxaparin Sodium APIs and Preparations Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Enoxaparin Sodium APIs and Preparations Consumption Value, 2019-2030
6.4 By Type, Global Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030
6.5 By Type, Global Enoxaparin Sodium APIs and Preparations Average Selling Price (ASP), 2019-2030
7 Sights by Application
7.1 Enoxaparin Sodium APIs and Preparations Segment by Application
7.1.1 Deep Vein Thrombosis
7.1.2 Pulmonary Embolism
7.1.3 Others
7.2 By Application, Global Enoxaparin Sodium APIs and Preparations Consumption Value & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Enoxaparin Sodium APIs and Preparations Consumption Value, 2019-2030
7.4 By Application, Global Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030
7.5 By Application, Global Enoxaparin Sodium APIs and Preparations Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Enoxaparin Sodium APIs and Preparations Consumption Value, 2019 VS 2024 VS 2030
8.2 By Region, Global Enoxaparin Sodium APIs and Preparations Consumption Value, 2019-2030
8.3 By Region, Global Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030
8.4 North America
8.4.1 North America Enoxaparin Sodium APIs and Preparations & Forecasts, 2019-2030
8.4.2 By Country, North America Enoxaparin Sodium APIs and Preparations Market Size Market Share
8.5 Europe
8.5.1 Europe Enoxaparin Sodium APIs and Preparations Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Enoxaparin Sodium APIs and Preparations Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Enoxaparin Sodium APIs and Preparations Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Enoxaparin Sodium APIs and Preparations Market Size Market Share
8.7 South America
8.7.1 South America Enoxaparin Sodium APIs and Preparations Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Enoxaparin Sodium APIs and Preparations Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Enoxaparin Sodium APIs and Preparations Market Size & CAGR, 2019 VS 2024 VS 2030
9.2 By Country, Global Enoxaparin Sodium APIs and Preparations Consumption Value, 2019-2030
9.3 By Country, Global Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030
9.4 U.S.
9.4.1 U.S. Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.4.2 By Type, U.S. Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.5.2 By Type, Europe Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.6.2 By Type, China Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.7.2 By Type, Japan Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.8.2 By Type, South Korea Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.9.2 By Type, Southeast Asia Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.10.2 By Type, India Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.11.2 By Type, Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Shandong Haike Chemical Group Co., Ltd
10.1.1 Shandong Haike Chemical Group Co., Ltd Company Information, Head Office, Market Area, and Industry Position
10.1.2 Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
10.1.3 Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Shandong Haike Chemical Group Co., Ltd Company Profile and Main Business
10.1.5 Shandong Haike Chemical Group Co., Ltd Recent Developments
10.2 Manus Aktteva Biopharma LLP
10.2.1 Manus Aktteva Biopharma LLP Company Information, Head Office, Market Area, and Industry Position
10.2.2 Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
10.2.3 Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Manus Aktteva Biopharma LLP Company Profile and Main Business
10.2.5 Manus Aktteva Biopharma LLP Recent Developments
10.3 Chemi SPA
10.3.1 Chemi SPA Company Information, Head Office, Market Area, and Industry Position
10.3.2 Chemi SPA Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
10.3.3 Chemi SPA Enoxaparin Sodium APIs and Preparations Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Chemi SPA Company Profile and Main Business
10.3.5 Chemi SPA Recent Developments
10.4 Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
10.4.1 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
10.4.2 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
10.4.3 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Company Profile and Main Business
10.4.5 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Recent Developments
10.5 Venus Remedies Ltd
10.5.1 Venus Remedies Ltd Company Information, Head Office, Market Area, and Industry Position
10.5.2 Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
10.5.3 Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Venus Remedies Ltd Company Profile and Main Business
10.5.5 Venus Remedies Ltd Recent Developments
10.6 JoinHub Pharma
10.6.1 JoinHub Pharma Company Information, Head Office, Market Area, and Industry Position
10.6.2 JoinHub Pharma Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
10.6.3 JoinHub Pharma Enoxaparin Sodium APIs and Preparations Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.6.4 JoinHub Pharma Company Profile and Main Business
10.6.5 JoinHub Pharma Recent Developments
10.7 Memphis Vision Care
10.7.1 Memphis Vision Care Company Information, Head Office, Market Area, and Industry Position
10.7.2 Memphis Vision Care Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
10.7.3 Memphis Vision Care Enoxaparin Sodium APIs and Preparations Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Memphis Vision Care Company Profile and Main Business
10.7.5 Memphis Vision Care Recent Developments
10.8 Shenzhen Techdow Pharmaceutical Co., Ltd.
10.8.1 Shenzhen Techdow Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
10.8.2 Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
10.8.3 Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Shenzhen Techdow Pharmaceutical Co., Ltd. Company Profile and Main Business
10.8.5 Shenzhen Techdow Pharmaceutical Co., Ltd. Recent Developments
10.9 Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
10.9.1 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Company Information, Head Office, Market Area, and Industry Position
10.9.2 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
10.9.3 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Company Profile and Main Business
10.9.5 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Recent Developments
10.10 Meithal Pharmaceuticals
10.10.1 Meithal Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.10.2 Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
10.10.3 Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Meithal Pharmaceuticals Company Profile and Main Business
10.10.5 Meithal Pharmaceuticals Recent Developments
10.11 Gland Pharma
10.11.1 Gland Pharma Company Information, Head Office, Market Area, and Industry Position
10.11.2 Gland Pharma Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
10.11.3 Gland Pharma Enoxaparin Sodium APIs and Preparations Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Gland Pharma Company Profile and Main Business
10.11.5 Gland Pharma Recent Developments
10.12 Dongying Tiandong Pharmaceutical Co., Ltd.
10.12.1 Dongying Tiandong Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
10.12.2 Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
10.12.3 Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Dongying Tiandong Pharmaceutical Co., Ltd. Company Profile and Main Business
10.12.5 Dongying Tiandong Pharmaceutical Co., Ltd. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Enoxaparin Sodium APIs and Preparations Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Enoxaparin Sodium APIs and Preparations Market Restraints
Table 3. Enoxaparin Sodium APIs and Preparations Market Trends
Table 4. Enoxaparin Sodium APIs and Preparations Industry Policy
Table 5. Global Enoxaparin Sodium APIs and Preparations Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Enoxaparin Sodium APIs and Preparations Revenue Share by Company, 2019-2024, Ranked by Data of 2022
Table 7. Global Enoxaparin Sodium APIs and Preparations Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Enoxaparin Sodium APIs and Preparations Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 9. Global Enoxaparin Sodium APIs and Preparations Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)
Table 10. Global Enoxaparin Sodium APIs and Preparations Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Enoxaparin Sodium APIs and Preparations Mergers & Acquisitions, Expansion Plans
Table 12. Global Enoxaparin Sodium APIs and Preparations Manufacturers Product Type
Table 13. Head Office and Enoxaparin Sodium APIs and Preparations Production Site of Key Manufacturer
Table 14. Enoxaparin Sodium APIs and Preparations Capacity of Major Manufacturers and Future Plan
Table 15. China Enoxaparin Sodium APIs and Preparations Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 16. China Enoxaparin Sodium APIs and Preparations Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022
Table 17. China Enoxaparin Sodium APIs and Preparations Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 18. Global Enoxaparin Sodium APIs and Preparations Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 19. Global Enoxaparin Sodium APIs and Preparations Production by Region, 2019-2024, (K Units)
Table 20. Global Enoxaparin Sodium APIs and Preparations Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Enoxaparin Sodium APIs and Preparations Upstream (Raw Materials)
Table 22. Global Enoxaparin Sodium APIs and Preparations Typical Customers
Table 23. Enoxaparin Sodium APIs and Preparations Typical Distributors
Table 24. By Type, Global Enoxaparin Sodium APIs and Preparations Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 25. By Application, Global Enoxaparin Sodium APIs and Preparations Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 26. By Region, Global Enoxaparin Sodium APIs and Preparations Consumption Value, 2019 VS 2024 VS 2030, US$ Million
Table 27. By Region, Global Enoxaparin Sodium APIs and Preparations Consumption Value, 2019-2030, US$ Million
Table 28. By Region, Global Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030, (K Units)
Table 29. By Country, Global Enoxaparin Sodium APIs and Preparations Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Country, Global Enoxaparin Sodium APIs and Preparations Consumption Value, 2019-2030, US$ Million
Table 31. By Country, Global Enoxaparin Sodium APIs and Preparations Consumption Value Market Share, 2019-2030
Table 32. By Country, Global Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030, (K Units)
Table 33. By Country, Global Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2019-2030
Table 34. Shandong Haike Chemical Group Co., Ltd Company Information, Head Office, Market Area, and Industry Position
Table 35. Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
Table 36. Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 37. Shandong Haike Chemical Group Co., Ltd Company Profile and Main Business
Table 38. Shandong Haike Chemical Group Co., Ltd Recent Developments
Table 39. Manus Aktteva Biopharma LLP Company Information, Head Office, Market Area, and Industry Position
Table 40. Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
Table 41. Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Manus Aktteva Biopharma LLP Company Profile and Main Business
Table 43. Manus Aktteva Biopharma LLP Recent Developments
Table 44. Chemi SPA Company Information, Head Office, Market Area, and Industry Position
Table 45. Chemi SPA Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
Table 46. Chemi SPA Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Chemi SPA Company Profile and Main Business
Table 48. Chemi SPA Recent Developments
Table 49. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 50. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
Table 51. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Company Profile and Main Business
Table 53. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Recent Developments
Table 54. Venus Remedies Ltd Company Information, Head Office, Market Area, and Industry Position
Table 55. Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
Table 56. Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Venus Remedies Ltd Company Profile and Main Business
Table 58. Venus Remedies Ltd Recent Developments
Table 59. JoinHub Pharma Company Information, Head Office, Market Area, and Industry Position
Table 60. JoinHub Pharma Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
Table 61. JoinHub Pharma Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. JoinHub Pharma Company Profile and Main Business
Table 63. JoinHub Pharma Recent Developments
Table 64. Memphis Vision Care Company Information, Head Office, Market Area, and Industry Position
Table 65. Memphis Vision Care Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
Table 66. Memphis Vision Care Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Memphis Vision Care Company Profile and Main Business
Table 68. Memphis Vision Care Recent Developments
Table 69. Shenzhen Techdow Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 70. Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
Table 71. Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Shenzhen Techdow Pharmaceutical Co., Ltd. Company Profile and Main Business
Table 73. Shenzhen Techdow Pharmaceutical Co., Ltd. Recent Developments
Table 74. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 75. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
Table 76. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Company Profile and Main Business
Table 78. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Recent Developments
Table 79. Meithal Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 80. Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
Table 81. Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. Meithal Pharmaceuticals Company Profile and Main Business
Table 83. Meithal Pharmaceuticals Recent Developments
Table 84. Gland Pharma Company Information, Head Office, Market Area, and Industry Position
Table 85. Gland Pharma Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
Table 86. Gland Pharma Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Gland Pharma Company Profile and Main Business
Table 88. Gland Pharma Recent Developments
Table 89. Dongying Tiandong Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 90. Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications, and Application
Table 91. Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. Dongying Tiandong Pharmaceutical Co., Ltd. Company Profile and Main Business
Table 93. Dongying Tiandong Pharmaceutical Co., Ltd. Recent Developments
List of Figures
Figure 1. Enoxaparin Sodium APIs and Preparations Picture
Figure 2. Global Enoxaparin Sodium APIs and Preparations Consumption Value, (US$ million) & (2019-2030)
Figure 3. Global Enoxaparin Sodium APIs and Preparations Sales Quantity, (K Units) & (2019-2030)
Figure 4. Global Enoxaparin Sodium APIs and Preparations Average Selling Price (ASP), (2019-2030) & (US$/Unit)
Figure 5. China Enoxaparin Sodium APIs and Preparations Consumption Value, (US$ million) & (2019-2030)
Figure 6. China Enoxaparin Sodium APIs and Preparations Sales Quantity (K Units) & (2019-2030)
Figure 7. China Enoxaparin Sodium APIs and Preparations Average Selling Price (ASP), (US$/Unit) & (2019-2030)
Figure 8. By Consumption Value, China Enoxaparin Sodium APIs and Preparations Market Share of Global, 2019-2030
Figure 9. By Sales Quantity, China Enoxaparin Sodium APIs and Preparations Market Share of Global, 2019-2030
Figure 10. Global Enoxaparin Sodium APIs and Preparations Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Enoxaparin Sodium APIs and Preparations Key Participants, Market Share, 2022
Figure 12. Global Enoxaparin Sodium APIs and Preparations Capacity, Production and Capacity Utilization, 2019-2030
Figure 13. Global Enoxaparin Sodium APIs and Preparations Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Enoxaparin Sodium APIs and Preparations Production Market Share & Forecast by Region, 2019-2030
Figure 15. Enoxaparin Sodium APIs and Preparations Industry Chain
Figure 16. Enoxaparin Sodium APIs and Preparations Procurement Model
Figure 17. Enoxaparin Sodium APIs and Preparations Sales Model
Figure 18. Enoxaparin Sodium APIs and Preparations Sales Channels, Direct Sales, and Distribution
Figure 19. 20 mg/0.2mL
Figure 20. 40 mg/0.4mL
Figure 21. 60 mg/0.6mL
Figure 22. 80 mg/0.8mL
Figure 23. 100 mg/1mL
Figure 24. 120 mg/0.8mL
Figure 25. 150 mg/1mL
Figure 26. 300mg/3mL
Figure 27. By Type, Global Enoxaparin Sodium APIs and Preparations Consumption Value, 2019-2030, US$ Million
Figure 28. By Type, Global Enoxaparin Sodium APIs and Preparations Consumption Value Market Share, 2019-2030
Figure 29. By Type, Global Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030, (K Units)
Figure 30. By Type, Global Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2019-2030
Figure 31. By Type, Global Enoxaparin Sodium APIs and Preparations Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 32. Deep Vein Thrombosis
Figure 33. Pulmonary Embolism
Figure 34. Others
Figure 35. By Application, Global Enoxaparin Sodium APIs and Preparations Consumption Value, 2019-2030, US$ Million
Figure 36. By Application, Global Enoxaparin Sodium APIs and Preparations Consumption Value Market Share, 2019-2030
Figure 37. By Application, Global Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030, (K Units)
Figure 38. By Application, Global Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2019-2030
Figure 39. By Application, Global Enoxaparin Sodium APIs and Preparations Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 40. By Region, Global Enoxaparin Sodium APIs and Preparations Consumption Value Market Share, 2019-2030
Figure 41. By Region, Global Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2019-2030
Figure 42. North America Enoxaparin Sodium APIs and Preparations Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 43. By Country, North America Enoxaparin Sodium APIs and Preparations Consumption Value Market Share, 2022
Figure 44. Europe Enoxaparin Sodium APIs and Preparations Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 45. By Country, Europe Enoxaparin Sodium APIs and Preparations Consumption Value Market Share, 2022
Figure 46. Asia Pacific Enoxaparin Sodium APIs and Preparations Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 47. By Country/Region, Asia Pacific Enoxaparin Sodium APIs and Preparations Consumption Value Market Share, 2022
Figure 48. South America Enoxaparin Sodium APIs and Preparations Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 49. By Country, South America Enoxaparin Sodium APIs and Preparations Consumption Value Market Share, 2022
Figure 50. Middle East & Africa Enoxaparin Sodium APIs and Preparations Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 51. U.S. Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030, (K Units)
Figure 52. By Type, U.S. Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, U.S. Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 54. Europe Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030, (K Units)
Figure 55. By Type, Europe Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Europe Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 57. China Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030, (K Units)
Figure 58. By Type, China Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, China Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 60. Japan Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030, (K Units)
Figure 61. By Type, Japan Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Japan Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 63. South Korea Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030, (K Units)
Figure 64. By Type, South Korea Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, South Korea Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 66. Southeast Asia Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030, (K Units)
Figure 67. By Type, Southeast Asia Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Southeast Asia Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 69. India Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030, (K Units)
Figure 70. By Type, India Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, India Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 72. Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity, 2019-2030, (K Units)
Figure 73. By Type, Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 74. By Application, Middle East & Africa Enoxaparin Sodium APIs and Preparations Sales Quantity Market Share, 2022 VS 2029
Figure 75. Research Methodology
Figure 76. Breakdown of Primary Interviews
Figure 77. Bottom-up and Top-down Approaches
Figure 78. Top-down Approaches
Research Methodology:
Enoxaparin Sodium APIs and Preparations Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|